Diversified Enterprises’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Diversified Enterprises's BMY Position: Q1 2026 in Review
Diversified Enterprises increased its Bristol-Myers Squibb (BMY) stake by 27% in Q1 2026, buying an estimated $148K and bringing the position to 11,967 shares worth $726K. The position accounts for 0.04% of the portfolio, ranked #190.
Diversified Enterprises first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Diversified Enterprises held 11,967 shares of Bristol-Myers Squibb worth $726K as of Q1 2026.
- Diversified Enterprises bought 2,533 Bristol-Myers Squibb shares in Q1 2026, an estimated $148K.
- Bristol-Myers Squibb made up 0.04% of Diversified Enterprises's portfolio in Q1 2026, its #190 holding.
- Diversified Enterprises first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Diversified Enterprises's 13F filing for Q1 2026, filed 15 May 2026.